Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-033020

Chief Financial Officer sold 57,765 shares at an average $101.78 ($5,879,089)

  • Chief Financial Officer acquired 47,889 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bonstein Sara · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-23 Exercise or conversion : show line 1 in the form 10b5-1 +35,253 $18.95 $668,044 138,665 D
2025-06-23 Exercise or conversion : show line 2 in the form 10b5-1 +12,636 $19.74 $249,435 151,301 D
2025-06-23 Sale : show line 3 in the form 10b5-1 −49,104 $101.71 $4,994,368 102,197 D
2025-06-23 Sale : show line 4 in the form 10b5-1 −8,661 $102.15 $884,721 93,536 D
Open-market sales · 57,765 sh · avg $101.78 · $5,879,089

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-06-23 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −35,253 99,007 D
2025-06-23 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −12,636 25,124 D
Loading xslF345X05/wk-form4_1750882708.xml…